Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
national blog main
life sciences
national top stories
san francisco blog main
boston blog main
detroit blog main
detroit top stories
national
new york blog main
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco top stories
wisconsin blog main
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
arboretum ventures
aurora health care
babies
baird capital
boston top stories
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer
cancer diagnostics
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr
crispr-cas9
dan rhodes
What
medicine
4
×
week
4
×
based
company
precision
ann
announced
arbor
area
bay
big
bio
biomedical
biopsy
bird
blood
bosley's
bosley’s
breakthroughs
bridge
bucks
buildout
cancer
cas
ceo
close
closed
conference
crime
crispr
departure
developing
diego’s
early
editas
ending
exit
firm
genomic
genomics
Language
unset
Current search:
biotech
×
week
×
medicine
×
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
